Pressure Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Pages: 29 Published: March 31, 2022 Report Code: GMDGDHC22082IDB

Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large amount of body fat and are in direct contact with a supporting surface (bed or a wheelchair). Causes include continuous pressure, friction, and shear. Treatment includes antibiotics and nutrition.

The Pressure Ulcers Drugs in Development market research report provides an overview of the Pressure Ulcers pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pressure Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects.

Pressure Ulcers Pipeline Drugs Market Targets

The targets of the pressure ulcers pipeline drugs market are Beta Nerve Growth Factor, Phosphodiesterase 5, and Soluble Guanylate Cyclase.

Pressure Ulcers pipeline drugs market, by targets

Pressure Ulcers pipeline drugs market, by targets

For more target insights, download a free report sample

Mechanisms of Action of Pressure Ulcers Pipeline Drugs Market

The mechanisms of action of the pressure ulcers pipeline drugs market Beta Nerve Growth Factor Activator, Phosphodiesterase 5 Inhibitor, and Soluble Guanylate Cyclase Activator.

Pressure Ulcers pipeline drugs market, by mechanisms of action

Pressure Ulcers pipeline drugs market, by mechanisms of action

For more mechanisms of action insights, download a free report sample

Routes of Administration in Pressure Ulcers Pipeline Drugs Market

The routes of administration in the pressure ulcers pipeline drugs market are topical, cutaneous, and ophthalmic.

Pressure Ulcers pipeline drugs market, by routes of administration

Pressure Ulcers pipeline drugs market, by routes of administration

For more routes of administration insights, download a free report sample

Molecule Types in Pressure Ulcers Pipeline Drugs Market

The molecule types in the pressure ulcers pipeline drugs market are small molecule, recombinant peptide, and synthetic peptide.

Pressure Ulcers pipeline drugs market, by molecule types

Pressure Ulcers pipeline drugs market, by molecule types

For more molecule type insights, download a free report sample

Key Pressure Ulcers Pipeline Drugs Market Companies

Some of the key companies in the pressure ulcers pipeline drugs market are EyeGene Inc, MimeTech Srl, NovaLead Pharma Pvt Ltd, Shionogi & Co Ltd, and Topadur Pharma AG.

Pressure Ulcers pipeline drugs market, by key companies

Pressure Ulcers pipeline drugs market, by key companies

To know more about key companies, download a free report sample

Market report overview

Targets Beta Nerve Growth Factor, Phosphodiesterase 5, and Soluble Guanylate Cyclase
Mechanisms of Action Beta Nerve Growth Factor Activator, Phosphodiesterase 5 Inhibitor, and Soluble Guanylate Cyclase Activator
Routes of Administration Topical, Cutaneous, and Ophthalmic
Molecule Types Small Molecule, Recombinant Peptide, and Synthetic Peptide
Key Companies EyeGene Inc, MimeTech Srl, NovaLead Pharma Pvt Ltd, Shionogi & Co Ltd, and Topadur Pharma AG

Scope

This report provides:

  • A snapshot of the global therapeutic landscape of Pressure Ulcers (Dermatology).
  • Reviews of pipeline therapeutics for Pressure Ulcers (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
  • Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
  • Reviews of key companies involved in Pressure Ulcers (Dermatology) therapeutics and enlists all their major and minor projects.
  • Evaluation of Pressure Ulcers (Dermatology) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
  • All the dormant and discontinued pipeline projects.
  • Reviews of the latest news and deals related to pipeline therapeutics for Pressure Ulcers (Dermatology).

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pressure Ulcers (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Pressure Ulcers (Dermatology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Players

EyeGene Inc

MimeTech Srl

NovaLead Pharma Pvt Ltd

Shionogi & Co Ltd

Topadur Pharma AG

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Pressure Ulcers – Overview

Pressure Ulcers – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Pressure Ulcers – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Pressure Ulcers – Companies Involved in Therapeutics Development

EyeGene Inc

MimeTech Srl

NovaLead Pharma Pvt Ltd

Shionogi & Co Ltd

Topadur Pharma AG

Pressure Ulcers – Drug Profiles

EG-Decorin – Drug Profile

Product Description

Mechanism Of Action

History of Events

NLP-328 – Drug Profile

Product Description

Mechanism Of Action

SR-0379 – Drug Profile

Product Description

Mechanism Of Action

History of Events

TOPN-53 – Drug Profile

Product Description

Mechanism Of Action

udonitrectag – Drug Profile

Product Description

Mechanism Of Action

History of Events

Pressure Ulcers – Dormant Projects

Pressure Ulcers – Discontinued Products

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development for Pressure Ulcers, 2022

Number of Products under Development by Companies, 2022

Products under Development by Companies, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Pressure Ulcers – Pipeline by EyeGene Inc, 2022

Pressure Ulcers – Pipeline by MimeTech Srl, 2022

Pressure Ulcers – Pipeline by NovaLead Pharma Pvt Ltd, 2022

Pressure Ulcers – Pipeline by Shionogi & Co Ltd, 2022

Pressure Ulcers – Pipeline by Topadur Pharma AG, 2022

Pressure Ulcers – Dormant Projects, 2022

Pressure Ulcers – Discontinued Products, 2022

List of Figures

List of Figures

Number of Products under Development for Pressure Ulcers, 2022

Number of Products under Development by Companies, 2022

Number of Products by Targets, 2022

Number of Products by Stage and Targets, 2022

Number of Products by Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Molecule Types, 2022

Frequently Asked Questions

Enquire Before Buying
$2000

Can be used by individual purchaser only

$6000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.